相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia
R. Peffault de Latour et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Predicting response of severe aplastic anemia to immunosuppression combined with eltrombopag
Yoshitaka Zaimoku et al.
HAEMATOLOGICA (2022)
Long-term outcomes in patients with severe aplastic anemia treated with immunosuppression and eltrombopag: a phase 2 study
Bhavisha A. Patel et al.
BLOOD (2022)
High-dose romiplostim accelerates hematologic recovery in patients with aplastic anemia refractory to eltrombopag
Kohei Hosokawa et al.
LEUKEMIA (2021)
Eltrombopag added to immunosuppression for children with treatment-naive severe aplastic anaemia
Emma M. Groarke et al.
BRITISH JOURNAL OF HAEMATOLOGY (2021)
Clinical and prognostic significance of small paroxysmal nocturnal hemoglobinuria clones in myelodysplastic syndrome and aplastic anemia
Bruno Fattizzo et al.
LEUKEMIA (2021)
Combined haploidentical and cord blood transplantation for refractory severe aplastic anaemia and hypoplastic myelodysplastic syndrome
Richard W. Childs et al.
BRITISH JOURNAL OF HAEMATOLOGY (2021)
Acquired severe aplastic anaemia: how medical therapy evolved in the 20th and 21st centuries
Phillip Scheinberg
BRITISH JOURNAL OF HAEMATOLOGY (2021)
The predictive value of PNH clones, 6p CN-LOH, and clonal TCR gene rearrangement for aplastic anemia diagnosis
Yash B. Shah et al.
BLOOD ADVANCES (2021)
HLA associations, somatic loss of HLA expression, and clinical outcomes in immune aplastic anemia
Yoshitaka Zaimoku et al.
BLOOD (2021)
Eltrombopag for patients with moderate aplastic anemia or uni-lineage cytopenias
Xing Fan et al.
BLOOD ADVANCES (2020)
Haploidentical BMT for severe aplastic anemia with intensive GVHD prophylaxis including posttransplant cyclophosphamide
Amy E. DeZern et al.
BLOOD ADVANCES (2020)
Very long-term follow-up of aplastic anemia treated with immunosuppressive therapy or allogeneic hematopoietic cell transplantation
Beatrice Drexler et al.
ANNALS OF HEMATOLOGY (2020)
Use of eltrombopag in aplastic anemia in Europe
Matyas Ecsedi et al.
ANNALS OF HEMATOLOGY (2019)
Clinical and morphological predictors of outcome in older aplastic anemia patients treated with eltrombopag
Bruno Fattizzo et al.
HAEMATOLOGICA (2019)
Treatment optimization and genomic outcomes in refractory severe aplastic anemia treated with eltrombopag
Thomas Winkler et al.
BLOOD (2019)
Hematologic recovery induced by eltrombopag in Japanese patients with aplastic anemia refractory or intolerant to immunosuppressive therapy
Hirohito Yamazaki et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2019)
Romiplostim in patients with refractory aplastic anaemia previously treated with immunosuppressive therapy: a dose-finding and long-term treatment phase 2 trial
Jong Wook Lee et al.
LANCET HAEMATOLOGY (2019)
Nationwide survey in France on the use of romiplostim in patients with refractory severe aplastic anemia
Lin-Pierre Zhao et al.
BONE MARROW TRANSPLANTATION (2019)
Aplastic Anemia
Neal S. Young
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Eltrombopag Added to Standard Immunosuppression for Aplastic Anemia
Danielle M. Townsley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Long-Term Outcomes of Cord Blood Transplantation from an HLA-Identical Sibling for Patients with Bone Marrow Failure Syndromes: A Report From Eurocord, Cord Blood Committee and Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation
Simona Pagliuca et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)
Somatic HLA mutations expose the role of class I-mediated autoimmunity in aplastic anemia and its clonal complications
Daria V. Babushok et al.
BLOOD ADVANCES (2017)
The role of paroxysmal nocturnal hemoglobinuria clones in response to immunosuppressive therapy of patients with severe aplastic anemia
Xin Zhao et al.
ANNALS OF HEMATOLOGY (2015)
Current outcome of HLA identical sibling versus unrelated donor transplants in severe aplastic anemia: an EBMT analysis
Andrea Bacigalupo et al.
HAEMATOLOGICA (2015)
Paroxysmal nocturnal hemoglobinuria and telomere length predicts response to immunosuppressive therapy in pediatric aplastic anemia
Atsushi Narita et al.
HAEMATOLOGICA (2015)
Somatic Mutations and Clonal Hematopoiesis in Aplastic Anemia
T. Yoshizato et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Eltrombopag in Aplastic Anemia
Ronan Desmond et al.
SEMINARS IN HEMATOLOGY (2015)
Current outcome of HLA identical sibling versus unrelated donor transplants in severe aplastic anemia: an EBMT analysis
Andrea Bacigalupo et al.
HAEMATOLOGICA (2015)
Paroxysmal nocturnal hemoglobinuria and telomere length predicts response to immunosuppressive therapy in pediatric aplastic anemia
Atsushi Narita et al.
HAEMATOLOGICA (2015)
Telomere attrition and candidate gene mutations preceding monosomy 7 in aplastic anemia
Bogdan Dumitriu et al.
BLOOD (2015)
Horse antithymocyte globulin as salvage therapy after rabbit antithymocyte globulin for severe aplastic anemia
Phillip Scheinberg et al.
AMERICAN JOURNAL OF HEMATOLOGY (2014)
Moderate-dose cyclophosphamide for severe aplastic anemia has significant toxicity and does not prevent relapse and clonal evolution
Phillip Scheinberg et al.
BLOOD (2014)
Somatic mutations identify a subgroup of aplastic anemia patients who progress to myelodysplastic syndrome
Austin G. Kulasekararaj et al.
BLOOD (2014)
Prognostic value of paroxysmal nocturnal haemoglobinuria clone presence in aplastic anaemia patients treated with combined immunosuppression: results of two-centre prospective study
Alexander Kulagin et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Thrombopoietin from beginning to end
Ian S. Hitchcock et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Aplastic Anemia: What Have We Learned From Animal Models and From the Clinic
Phillip Scheinberg et al.
SEMINARS IN HEMATOLOGY (2013)
Activity of alemtuzumab monotherapy in treatment-naive, relapsed, and refractory severe acquired aplastic anemia
Phillip Scheinberg et al.
BLOOD (2012)
Eltrombopag and Improved Hematopoiesis in Refractory Aplastic Anemia
Matthew J. Olnes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Long-term follow-up of clonal evolutions in 802 aplastic anemia patients: a single-center experience
Yingmei Li et al.
ANNALS OF HEMATOLOGY (2011)
A randomized controlled study in patients with newly diagnosed severe aplastic anemia receiving antithymocyte globulin (ATG), cyclosporine, with or without G-CSF: a study of the SAA Working Party of the European Group for Blood and Marrow Transplantation
Andre Tichelli et al.
BLOOD (2011)
Cytokine signature profiles in acquired aplastic anemia and myelodysplastic syndromes
Xingmin Feng et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Horse versus Rabbit Antithymocyte Globulin in Acquired Aplastic Anemia
Phillip Scheinberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Paroxysmal nocturnal hemoglobinuria clones in severe aplastic anemia patients treated with horse anti-thymocyte globulin plus cyclosporine
Phillip Scheinberg et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Association of Telomere Length of Peripheral Blood Leukocytes With Hematopoietic Relapse, Malignant Transformation, and Survival in Severe Aplastic Anemia
Phillip Scheinberg et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Predicting response to immunosuppressive therapy and survival in severe aplastic anaemia
Phillip Scheinberg et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Treatment of severe aplastic anemia with a combination of horse antithymocyte globulin and cyclosporine, with or without sirolimus: a prospective randomized study
Phillip Scheinberg et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Hematopoietic growth factors in aplastic anemia patients treated with immunosuppressive therapy: systematic review and meta-analysis
Ronit Gurion et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Lymphocytes with Aberrant Expression of Fas or Fas Ligand Attenuate Immune Bone Marrow Failure in a Mouse Model
Stephanie O. Omokaro et al.
JOURNAL OF IMMUNOLOGY (2009)
The epidemiology of acquired aplastic anemia
Neal S. Young et al.
HAEMATOLOGICA (2008)
Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura
James B. Bussel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Deficient CD4+ CD25+ FOXP3+ T regulatory cells in acquired aplastic anemia
Elena E. Solomou et al.
BLOOD (2007)
Minor antigen H60-mediated aplastic anemia is ameliorated by immunosuppression and the infusion of regulatory T cells
Jichun Chen et al.
JOURNAL OF IMMUNOLOGY (2007)
Current concepts in the pathophysiology and treatment of aplastic anemia
Neal S. Young et al.
BLOOD (2006)
Retreatment with rabbit anti-thymocyte globulin and ciclosporin for patients with relapsed or refractory severe aplastic anaemia
P Scheinberg et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Treatment of severe aplastic anaemia with combined immunosuppression: anti-thymocyte globulin, ciclosporin and mycophenolate mofetil
P Scheinberg et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Minor population of CD55-CD59- blood cells predicts response to immunosuppressive therapy and prognosis in patients with aplastic anemia
C Sugimori et al.
BLOOD (2006)
The epidemiology of aplastic anemia in Thailand
S Issaragrisil et al.
BLOOD (2006)
Relative incidence of agranulocytosis and aplastic anemia
DW Kaufman et al.
AMERICAN JOURNAL OF HEMATOLOGY (2006)
Immunosuppressive therapy for aplastic anemia in children:: a more severe disease predicts better survival
M Führer et al.
BLOOD (2005)
In-vivo dominant immune responses in aplastic anaemia:: molecular tracking of putatively pathogenetic T-cell clones by TCR β-CDR3 sequencing
AM Risitano et al.
LANCET (2004)
A mouse model of lymphocyte infusion-induced bone marrow failure
ML Bloom et al.
EXPERIMENTAL HEMATOLOGY (2004)
Antithymocyte globulin and cyclosporine for severe aplastic anemia - Association between hematologic response and long-term outcome
S Rosenfeld et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Acquired aplastic anemia
NS Young
ANNALS OF INTERNAL MEDICINE (2002)
High-dose cyclophosphamide in severe aplastic anaemia: a randomised trial
JF Tisdale et al.
LANCET (2000)
Treatment of acquired severe aplastic anemia: Bone marrow transplantation compared with immunosuppressive therapy - The European Group for Blood and Marrow Transplantation Experience
A Bacigalupo et al.
SEMINARS IN HEMATOLOGY (2000)
分享论文
